Gilman Clinic-Imh Gilman, IL - 60938

Gilman Clinic-Imh is categorized under Hospital, Affiliated With Ama Residency in Gilman, IL .

Gilman Clinic-Imh was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Hospital, Affiliated With Ama Residency business, which does work in the B2C market, and is classified as a Hospital, Affiliated With Ama Residency, under code number 6214930 by the NAICS.

If you are seeking more information, feel free to contact Michelle Fox, Director at the company’s single location by writing to 508 East Crescent St, Gilman, Illinois IL 60938 or by phoning (815) 265-8889. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Gilman Clinic-Imh
Contact Person: Michelle Fox, Director
Address: 508 East Crescent St, Gilman, Illinois 60938
Phone Number: (815) 265-8889
Website Address: iroquoismemorial.com
Annual Revenue (USD): $1.000.000 to $2.499.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Hospital, Affiliated With Ama Residency
SIC Code: 8062
NAICS Code: 6214930
Share This Business:

Gilman Clinic-Imh was started in 0 to provide professional Hospital, Affiliated With Ama Residency under the SIC code 8062 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Michelle Fox, Director for inquiries that concern Gilman Clinic-Imh by calling the company number (815) 265-8889, as your correspondence is most welcome. Additionally, the physical location of the single location of Gilman Clinic-Imh can be found at the coordinates 40.76657,-87.98595 as well as the street address 508 East Crescent St in Gilman, Illinois 60938.

For its online presence, you may visit Gilman Clinic-Imh’s website at iroquoismemorial.com and engage with its social media outlets through on Twitter and on Facebook.